Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (AML-19)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by European Organisation for Research and Treatment of Cancer - EORTC.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Information provided by (Responsible Party):
European Organisation for Research and Treatment of Cancer - EORTC
ClinicalTrials.gov Identifier:
NCT00091234
First received: September 7, 2004
Last updated: July 23, 2012
Last verified: July 2012